This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Oxford University Innovation Ltd. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Filip Wyszynski: Innovator in Tunicamycin Analogues
Introduction
Filip Wyszynski is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tunicamycin analogues. His work focuses on creating compounds that can aid in the prevention and treatment of bacterial infections, including tuberculosis.
Latest Patents
Wyszynski holds a patent for tunicamycin analogues, which are compounds defined by a specific formula. These compounds, or their pharmaceutically acceptable salts, are designed to combat bacterial infections effectively. The invention is particularly relevant in the fight against tuberculosis, a serious global health issue.
Career Highlights
Filip Wyszynski is associated with Oxford University Innovation Ltd, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on public health and the pharmaceutical industry.
Collaborations
Wyszynski collaborates with esteemed colleagues, including Benjamin Guy Davis and Hua Wang. These partnerships enhance the research and development process, fostering innovation in the field.
Conclusion
Filip Wyszynski's contributions to the development of tunicamycin analogues represent a significant advancement in the fight against bacterial infections. His work at Oxford University Innovation Ltd highlights the importance of innovation in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile